Which of the following is a risk factor for developing multidrug-resistant TB?

Which of the following is a risk factor for developing multidrug-resistant TB?

• A. Inadequate treatment of previous TB infections
• B. Low exposure to TB pathogens
• C. Short duration of prior TB treatment
• D. Good compliance with TB therapy

Answer: (A)

The presence of inadequate treatment of previous TB infections is a significant risk factor for developing multidrug-resistant tuberculosis (MDR-TB). When a patient does not receive the full or proper course of treatment for tuberculosis, the bacteria have the opportunity to survive and mutate, which can lead to resistance against multiple antitubercular medications. This can happen if a patient fails to adhere to their medication regimen, experiences side effects that are not adequately managed, or receives insufficient dosages or incorrect drug combinations. In contrast, low exposure to TB pathogens would generally decrease the risk of developing TB and, by extension, multidrug-resistant TB. Short duration of prior TB treatment can contribute to the risk of resistance if the treatment is not effective, but it is not as directly linked to the development of MDR-TB as inadequate treatment. Lastly, good compliance with TB therapy is crucial to successfully eradicate the infection and prevent the emergence of resistant strains. Therefore, these factors highlight the importance of thorough and effective treatment regimens in controlling TB and preventing resistance.

The presence of inadequate treatment of previous TB infections is a significant risk factor for developing multidrug-resistant tuberculosis (MDR-TB). When a patient does not receive the full or proper course of treatment for tuberculosis, the bacteria have the opportunity to survive and mutate, which can lead to resistance against multiple antitubercular medications. This can happen if a patient fails to adhere to their medication regimen, experiences side effects that are not adequately managed, or receives insufficient dosages or incorrect drug combinations.

In contrast, low exposure to TB pathogens would generally decrease the risk of developing TB and, by extension, multidrug-resistant TB. Short duration of prior TB treatment can contribute to the risk of resistance if the treatment is not effective, but it is not as directly linked to the development of MDR-TB as inadequate treatment. Lastly, good compliance with TB therapy is crucial to successfully eradicate the infection and prevent the emergence of resistant strains. Therefore, these factors highlight the importance of thorough and effective treatment regimens in controlling TB and preventing resistance.